pyruvic acid has been researched along with ximelagatran in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, U; Bäckström, J; Balasubramanian, R; Cederbrant, K; Glinghammar, B; Hannula, M; Juhasz, PJ; Kolmert, J; Lindberg, J; Marcusson-Ståhl, M; Martin, S; Nilsson, K; Nord, L; Schuppe-Koistinen, I; Wang, S; Zeng, C | 1 |
1 other study(ies) available for pyruvic acid and ximelagatran
Article | Year |
---|---|
A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran.
Topics: Adenosine Triphosphate; Alanine Transaminase; Azetidines; Benzylamines; Biomarkers; Blood Proteins; Cells, Cultured; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Complement C4b-Binding Protein; Female; Hepatocytes; Histocompatibility Antigens; Humans; Macrophages; Male; Metabolomics; Protein S; Proteomics; Pyruvic Acid; Receptor, Macrophage Colony-Stimulating Factor; Systems Biology; Tumor Cells, Cultured; Vitamin D-Binding Protein | 2009 |